TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23564056

Group type: EXPERIMENTAL
Intervention: Protamine based on heparin concentration measured after CPB (Group 2)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Protamine dose based on initial heparin dose (Group 1)
Number of subjects: 30
Study: 22415336

Group type: EXPERIMENTAL
Intervention: Increased intake of saturated fat
Number of subjects: 1261

Group type: EXPERIMENTAL
Intervention: Consumption of additional whole-grain bread (50 g/1000 kcal)
Number of subjects: 1261

Group type: EXPERIMENTAL
Intervention: Intake of dietary fiber (g/1000 kcal)
Number of subjects: 1261
Study: 20428109

Group type: EXPERIMENTAL
Intervention: Cognitive training
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 21
Study: 19137768

Group type: EXPERIMENTAL
Intervention: 20 mg of doxycycline taken twice daily
Number of subjects: 100

Group type: COMPARATOR
Intervention: 100 mg of doxycycline taken twice daily
Number of subjects: 100
Study: 15990606

Group type: EXPERIMENTAL
Intervention: Postmenopausal hormone replacement therapy (HRT)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Control group (never received HRT)
Number of subjects: 214
Study: 12421059

Group type: EXPERIMENTAL
Intervention: Phonological priming paradigm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modified standard priming experiment
Number of subjects: 0
Study: 10624544

Group type: EXPERIMENTAL
Intervention: Lithium (1200 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 8749685

Group type: EXPERIMENTAL
Intervention: Immunoglobulin light chains from hemodialysis patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immunoglobulin light chains from continuous ambulatory peritoneal dialysis patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Free immunoglobulin light chains
Number of subjects: 0
Study: 2045522

Group type: EXPERIMENTAL
Intervention: Acacia gum
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sugar-free gum
Number of subjects: 0
Study: 6989592

Group type: EXPERIMENTAL
Intervention: Intensified therapy (dietary intensive care, Biguanides, Clofibrate)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Routine method (control group)
Number of subjects: 150
Study: 31498154

Group type: EXPERIMENTAL
Intervention: Narrow-band imaging (NBI)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Combined NBI and Indigo Carmine Chromoendoscopy (ICC)
Number of subjects: 138
Study: 29885068

Group type: EXPERIMENTAL
Intervention: Nangibotide (1 mg, 10 mg, and doses ranging from 0.03 to 6 mg kg-1 h-1)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Nangibotide (various doses)
Number of subjects: 27
Study: 27289490

Group type: EXPERIMENTAL
Intervention: 500IR
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: 300IR
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: 100IR
Number of subjects: 355

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 355
Study: 25052595

Group type: EXPERIMENTAL
Intervention: Intravenous voriconazole (100 mg two times per day until neutrophils greater than 0.5×10⁹/L)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Oral fluconazole (200 mg per day)
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Overall survival comparison between patients with or without IFD
Number of subjects: 227

Group type: COMPARATOR
Intervention: Comparison of IFD incidence between voriconazole and fluconazole groups
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Liver function abnormalities
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Auditory hallucination and visual impairment due to voriconazole
Number of subjects: 227
Study: 22613649

Group type: EXPERIMENTAL
Intervention: Oxymatrine (600 mg intravenous infusion once a day for a month, then 200 mg oral capsule three times a day)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (silibin meglumine tablet only, same method and dosage as treatment group)
Number of subjects: 65
Study: 20955605

Group type: EXPERIMENTAL
Intervention: Exercise training (supervised aerobic interval training sessions, one hour, up to three times weekly)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 60
Study: 18946302

Group type: EXPERIMENTAL
Intervention: 0.1% bupivacaine and 2 microg/ml fentanyl (group BF)
Number of subjects: 32

Group type: COMPARATOR
Intervention: 0.1% bupivacaine (group B)
Number of subjects: 32
Study: 16096533

Group type: EXPERIMENTAL
Intervention: rFVIIa (200, 100, and 100 microg/kg)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study: 12756490

Group type: EXPERIMENTAL
Intervention: Selenium
Number of subjects: 32400

Group type: EXPERIMENTAL
Intervention: Vitamin E
Number of subjects: 32400

Group type: EXPERIMENTAL
Intervention: Selenium and Vitamin E combination
Number of subjects: 32400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32400
Study: 10739391

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (NO) at 5 ppm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (NO) at 10 ppm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (NO) at 40 ppm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (NO) at 5, 10, and 40 ppm
Number of subjects: 0
Study: 8737211

Group type: EXPERIMENTAL
Intervention: Primary angioplasty
Number of subjects: 301

Group type: COMPARATOR
Intervention: Intravenous streptokinase
Number of subjects: 301
Study: 1533479

Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BCG vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inactivated polio vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simultaneous administration of hepatitis B vaccine, BCG, and inactivated polio vaccine
Number of subjects: 0
Study: 3909373

Group type: EXPERIMENTAL
Intervention: RP 40 749
Number of subjects: 6

Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 6
Study: 30789910

Group type: EXPERIMENTAL
Intervention: Pentamidine prophylaxis for patients with CD4 <200 cells/μL
Number of subjects: 54

Group type: COMPARATOR
Intervention: No prophylaxis for patients with CD4 ≤200 cells/μL
Number of subjects: 54
Study: 28952009

Group type: EXPERIMENTAL
Intervention: Information pack
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no information pack)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Parents with more than one sweat test
Number of subjects: 32
Study: 27101823

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) intervention over 8 weeks
Number of subjects: 418

Group type: COMPARATOR
Intervention: Waitlist usual care regimen (control)
Number of subjects: 418
Study: 24005641

Group type: EXPERIMENTAL
Intervention: Indirect optical laryngoscopy (Airtraq, Prodol, Spain)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Video laryngoscopy (McGrath, Aircraft Medical, UK)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Direct laryngoscopy (Macintosh blade #3)
Number of subjects: 24
Study: 23127215

Group type: EXPERIMENTAL
Intervention: Fruit/vegetable juice
Number of subjects: 2397

Group type: EXPERIMENTAL
Intervention: Whole fruits/vegetables
Number of subjects: 2397
Study: 20484945

Group type: EXPERIMENTAL
Intervention: Multi-component intervention
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 78
Study: 18405245

Group type: EXPERIMENTAL
Intervention: Tacrolimus (group TAC)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (group MMF)
Number of subjects: 212
Study: 15809382

Group type: EXPERIMENTAL
Intervention: Oxycodone (0.1 mg/kg)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 63
Study: 12433703

Group type: EXPERIMENTAL
Intervention: Variant alleles at XRCC1 codon 194
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Variant alleles at XRCC1 codon 399
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Variant at XRCC1 codon 280
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Homozygous for common allele at codon 399 with low dietary intake of vitamin E
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Homozygous for common allele at codon 399 with low dietary intake of lycopene
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Low intake of vitamin C, A, or beta‐carotene
Number of subjects: 260
Study: 9435325

Group type: EXPERIMENTAL
Intervention: Leuprolide
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Leuprolide + Estradiol or Progesterone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 8003644

Group type: EXPERIMENTAL
Intervention: 1 million units of lymphoblastoid IFN-alpha daily for 2 weeks
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 3 million units of lymphoblastoid IFN-alpha daily for 2 weeks
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 6 million units of lymphoblastoid IFN-alpha daily for 2 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 80
Study: 2809902

Group type: EXPERIMENTAL
Intervention: Methionyl growth hormone, 2 IU/m2 subcutaneously once daily (group 1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Methionyl growth hormone, 4 IU/m2/day (group 1B)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Authentic biosynthetic growth hormone (group 2)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No therapy (group 3)
Number of subjects: 30
Study: 1106217

Group type: EXPERIMENTAL
Intervention: Lithium combined with major tranquilizers
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 31746743

Group type: EXPERIMENTAL
Intervention: Drug-coated balloon (Agent)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Standard drug-coated balloon (SeQuent Please)
Number of subjects: 125
Study: 29448235

Group type: EXPERIMENTAL
Intervention: Educational app
Number of subjects: 96

Group type: COMPARATOR
Intervention: Cartoon
Number of subjects: 96
Study: 27746555

Group type: EXPERIMENTAL
Intervention: Esmolol (500 μg/kg IV bolus followed by 100 μg/kg/min infusion)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 μg/kg IV bolus followed by 0.2 μg/kg/h infusion)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (0.9% IV)
Number of subjects: 60
Study: 24750511

Group type: EXPERIMENTAL
Intervention: Inferior pedicle reduction mammoplasty
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Higher resection weight
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Increased BMI
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Ex-smokers
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Never smoked
Number of subjects: 67
Study: 22678104

Group type: EXPERIMENTAL
Intervention: (R)-α-lipoic acid (LA) supplementation
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 20599163

Group type: EXPERIMENTAL
Intervention: Multiple paclitaxel-eluting stents (n=50)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Single paclitaxel-eluting stents (n=134)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Single paclitaxel-eluting stents (n=20)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Multiple paclitaxel-eluting stents (n=10)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Single paclitaxel-eluting stents
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Multiple paclitaxel-eluting stents
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Changes of vessel and lumen at overlapping PES segment
Number of subjects: 184
Study: 18586996

Group type: EXPERIMENTAL
Intervention: Pharmacological treatment indicators
Number of subjects: 807

Group type: EXPERIMENTAL
Intervention: General care and psychosocial rehabilitation indicators
Number of subjects: 807

Group type: EXPERIMENTAL
Intervention: Moderators affecting care conformance
Number of subjects: 807
Study: 16076789

Group type: EXPERIMENTAL
Intervention: Educational workshop, opinion leader influence, and prompts (progress notes, patient letters, or computer chart reminders)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control sites (no intervention)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Three prompt groups (progress notes, patient letters, computer chart reminders)
Number of subjects: 92
Study: 11795674

Group type: EXPERIMENTAL
Intervention: Lactobin (56g/day for 3 days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 10445766

Group type: EXPERIMENTAL
Intervention: Intrathecal methylprednisolone acetate (MPA), 60 mg administered four times at 1-week intervals.
Number of subjects: 25

Group type: COMPARATOR
Intervention: Epidural methylprednisolone acetate (MPA), 60 mg administered four times at 1-week intervals.
Number of subjects: 25
Study: 7829618

Group type: EXPERIMENTAL
Intervention: Finasteride (5 mg, orally, daily)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Spironolactone (100 mg, orally, daily)
Number of subjects: 14
Study: 2791157

Group type: EXPERIMENTAL
Intervention: Ever-Young Pill (EYP)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Nootropil
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study: 214701

Group type: EXPERIMENTAL
Intervention: Beta-Sitosterol 5.28 g
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Beta-Sitosterol 10.56 g
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 7060328

Group type: EXPERIMENTAL
Intervention: 975‐mg oral doses of aspirin
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 30325888

Group type: EXPERIMENTAL
Intervention: Cervical Disc Arthroplasty (CDA)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Anterior Cervical Decompression and Fusion (ACDF)
Number of subjects: 232
Study: 30049471

Group type: EXPERIMENTAL
Intervention: .04 taper instrumentation
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: .06 taper instrumentation
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: .08 taper instrumentation
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Conservative access cavity (CAC)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Traditional access cavity (TAC)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Intact teeth
Number of subjects: 78
Study: 26786399

Group type: EXPERIMENTAL
Intervention: Ultra-low-dose estriol vaginal gel 20 μg/g (T1)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Ultra-low-dose estriol vaginal gel 50 μg/g (T2)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Ovestinon® (estriol 500 μg/0.5 g) (R)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 24942563

Group type: EXPERIMENTAL
Intervention: Low-intensity extracorporeal shockwave therapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 70
Study: 21885390

Group type: EXPERIMENTAL
Intervention: HFO-TGI group (n = 61) receiving HFO-TGI sessions with recruitment manoeuvres (RMs) interspersed with lung-protective conventional mechanical ventilation (CMV)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: HFO-TGI group (n = 61)
Number of subjects: 125

Group type: COMPARATOR
Intervention: CMV group (n = 64)
Number of subjects: 125
Study: 20126672

Group type: EXPERIMENTAL
Intervention: Pixantrone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other agents (control)
Number of subjects: 0
Study: 17617293

Group type: EXPERIMENTAL
Intervention: Generic azithromycin (2 x 250 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Branded azithromycin (2 x 250 mg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 14
Study: 14693612

Group type: EXPERIMENTAL
Intervention: IV propacetamol 2 g (followed by 1 g)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: IM morphine 10 mg (followed by 5 mg)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Propacetamol vs Morphine
Number of subjects: 95
Study: 12161386

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 9829638

Group type: COMPARATOR
Intervention: Zidovudine (ZDV)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Saquinavir (SQV)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Combination therapy (SQV + ZDV)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Zidovudine (ZDV) or Saquinavir (SQV) monotherapies
Number of subjects: 44
Study: 8180293

Group type: EXPERIMENTAL
Intervention: Oral pantoprazole 40 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral pantoprazole 60 mg and 80 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous pantoprazole 40 mg
Number of subjects: 0
Study: 2689263

Group type: EXPERIMENTAL
Intervention: Bipolar probe coagulation (BICAP)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Conventional cold biopsy (CBx)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: BICAP and CBx (combined)
Number of subjects: 156
Study: 1106208

Group type: EXPERIMENTAL
Intervention: 0.5 ml/kg body weight of 95% ethanol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1.0 ml/kg body weight of 95% ethanol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 8 mg delta‐9‐tetrahydrocannabinol (THC)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 15 mg delta‐9‐tetrahydrocannabinol (THC)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31349677

Group type: EXPERIMENTAL
Intervention: Listening to music with normal visual perception
Number of subjects: 50

Group type: COMPARATOR
Intervention: Without music with normal visual perception
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: With music with normal visual perception
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: With reduced visual perception (ski goggles with occlusion foil)
Number of subjects: 50
Study: 28027462

Group type: EXPERIMENTAL
Intervention: Asymmetric force condition (left limb producing 5 times more force than right limb)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Symmetric force condition
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Asymmetric force condition (general)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Asymmetric force condition (left limb)
Number of subjects: 20
Study: 26022815

Group type: EXPERIMENTAL
Intervention: True air purifiers
Number of subjects: 35

Group type: COMPARATOR
Intervention: Sham air purifiers
Number of subjects: 35
Study: 23497457

Group type: EXPERIMENTAL
Intervention: Vasopressin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Norepinephrine
Number of subjects: 20
Study: 21208586

Group type: EXPERIMENTAL
Intervention: L-theanine (400 mg/d)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 19282081

Group type: EXPERIMENTAL
Intervention: Exaggeration
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Suppression
Number of subjects: 109

Group type: COMPARATOR
Intervention: Natural-watch
Number of subjects: 109
Study: 17229769

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (CHM)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 15005871

Group type: EXPERIMENTAL
Intervention: High dose of ethanol (0.8 g/kg for males and 0.7 g/kg for females)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Medium dose of ethanol (75% of the high dose)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 10391561

Group type: EXPERIMENTAL
Intervention: Beta-carotene (20 mg/day)
Number of subjects: 29133

Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol (50 mg/day)
Number of subjects: 29133
Study: 8664090

Group type: EXPERIMENTAL
Intervention: Paracetamol/codeine combination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paracetamol alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1640520

Group type: EXPERIMENTAL
Intervention: Transurethral intravesical electrotherapy (2 courses of 3 weeks each)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sham control (electrocatheter placed without activating the stimulator)
Number of subjects: 31
Study: 6373097

Group type: EXPERIMENTAL
Intervention: salbutamol
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: atropine (two doses)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: chlorpheniramine
Number of subjects: 21

Group type: COMPARATOR
Intervention: 0.9% NaCl solution (control)
Number of subjects: 21
Study: 30773797

Group type: EXPERIMENTAL
Intervention: SEPARPROCATH® radiation drape
Number of subjects: 51
Study: 29514852

Group type: EXPERIMENTAL
Intervention: Handover education and cognitive aid for the intervention group
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study: 28011970

Group type: EXPERIMENTAL
Intervention: Zinc sulphate
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 23846561

Group type: EXPERIMENTAL
Intervention: Text messaging intervention
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 1200
Study: 23706623

Group type: EXPERIMENTAL
Intervention: Carbon monoxide feedback in a computerized motivational intervention
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group (brief motivational intervention without carbon monoxide feedback)
Number of subjects: 124
Study: 20834180

Group type: EXPERIMENTAL
Intervention: Hericium erinaceus (HE) cookies for 4 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo cookies for 4 weeks
Number of subjects: 30
Study: 18256990

Group type: EXPERIMENTAL
Intervention: NMO-IgG antibody marker
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preliminary in vitro studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Development of active immunization and passive transfer animal models
Number of subjects: 0
Study: 15766322

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vardenafil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tadalafil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intracavernous administration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alprostadil products
Number of subjects: 0

Group type: COMPARATOR
Intervention: All PDE5 inhibitors
Number of subjects: 0